Pregnant woman

Halting certain medication for pregnant women could save NHS £20m a year, study shows

The NHS could be set to save £20m per year after a new study showed that a medication for inherited blood clotting doesn’t increase the chance of a successful pregnancy.

The ALIFE2 trial found the drug known as heparin, which is typically prescribed to pregnant women with acquired blood clotting disorders, is not effective for pregnant women with an inherited blood clotting condition called thrombophilia.

To conduct their research, health professionals recruited 326 women from 40 hospitals around the world who had inherited thrombophilia and two or more miscarriages.

Around half of the women received daily injections of heparin starting from their positive pregnancy test right up until labour. The other half were not offered the medication.

The study, which was funded by the National Institute for Health and Care Research, showed that the rate of live births was similar while the risk of complications like placental abruption, pre-eclampsia and premature birth were also about the same across both groups.

Deputy director at Tommy’s National Centre for Miscarriage Research, Professor Siobhan Quenby, led the research.

"Many women with recurrent miscarriage around the world are tested for inherited thrombophilia and are treated with heparin daily,” said Prof Quenby.

“Research now shows that this screening is not needed, the treatment isn’t effective, and it is giving false hope to many by continuing to offer it as a potential preventive treatment."

The researchers say that if the NHS ended the screening and stopped treating inherited thrombophilia with heparin, it could save approximately £20m annually.

Read the full study findings here.

Website cover

NHE May/June 2024

Join the conversation shaping the future of healthcare.

Click below to read more!

More articles...

View all
Online Conference


2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Listen to industry leaders on everything within healthcare

Whether it's the latest advancements in medical technology, healthcare policies, patient care innovations, or the challenges facing healthcare providers, we cover it all.


Join us as we engage with top healthcare professionals, industry leaders, and policy experts to bring you insightful conversations that matter.